Literature DB >> 667448

The interaction between methotrexate and probenecid in man [proceedings].

G W Aherne, V Marks, G P Mould, E Piall, W F White.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 667448      PMCID： PMC1668345     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  2 in total

1.  Methotrexate pharmacokinetics.

Authors:  K B Bischoff; R L Dedrick; D S Zaharko; J A Longstreth
Journal:  J Pharm Sci       Date:  1971-08       Impact factor: 3.534

2.  Inhibition of renal tubular transport of methotrexate by probenecid.

Authors:  R S Bourke; G Chheda; A Bremer; O Watanabe; D B Tower
Journal:  Cancer Res       Date:  1975-01       Impact factor: 12.701
  2 in total
  4 in total

Review 1.  [Methotrexate in the therapy of juvenile idiopathic arthritis].

Authors:  D Holzinger; M Frosch; D Föll
Journal:  Z Rheumatol       Date:  2010-08       Impact factor: 1.372

Review 2.  Clinical pharmacokinetics of probenecid.

Authors:  R F Cunningham; Z H Israili; P G Dayton
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

Review 3.  Review of Urate-Lowering Therapeutics: From the Past to the Future.

Authors:  Christopher Jenkins; Jennifer H Hwang; Jeffrey B Kopp; Cheryl A Winkler; Sung Kweon Cho
Journal:  Front Pharmacol       Date:  2022-08-23       Impact factor: 5.988

4.  PBPK modeling to predict drug-drug interactions of ivosidenib as a perpetrator in cancer patients and qualification of the Simcyp platform for CYP3A4 induction.

Authors:  Jayaprakasam Bolleddula; Alice Ke; Hua Yang; Chandra Prakash
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-05-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.